4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-033646
Chief Scientific Officer sold 15,177 shares at $90.00 ($1,365,930)
- Chief Scientific Officer acquired 15,177 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-05-23 | Option exercise | +15,177 | $31.64 | $480,200 | 72,373 | D |
| Biller Scott Chief Scientific Officer | 2018-05-23 | Sale | −15,177 | $90.00 | $1,365,930 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-05-23 | Option exercise · Stock options (right to buy) | +15,177 | 14,862 | D | ||
| Open-market sales · 15,177 sh · avg $90.00 · $1,365,930 | |||||||
Loading xslF345X03/doc4.xml…